About VASCUGEN, INC.
Vascugen is a biotechnology company focused on developing regenerative medicines to treat ischemic conditions through vasculogenic cell therapies. Their approach aims to directly restore blood flow by forming new blood vessels, targeting severe vascular diseases such as critical limb ischemia and diabetic retinopathy.
Is this your company?
Claim VASCUGEN, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim VASCUGEN, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.